TipRanks
Captor Therapeutics SA (PL:CTX)
:CTX
Poland Market
CTX
Captor Therapeutics SA
RESEARCH TOOLSreports
Want to see PL:CTX full AI Analyst Report?

Captor Therapeutics SA (CTX) Income Statement

1 Followers

Captor Therapeutics SA Income Statement

Last quarter (Q4 2025), Captor Therapeutics SA's total revenue was zł44.00K, a decrease of -98.51% from the same quarter last year. In Q4, Captor Therapeutics SA's net income was zł-10.05M. See Captor Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Dec 21
Total Revenue
zł 4.66Mzł 15.82Mzł 13.20Mzł 9.16Mzł 3.99M
Gross Profit
zł -652.00Kzł 6.42Mzł 6.90Mzł 7.07Mzł 3.25M
Operating Expenses
zł 52.55Mzł 51.18Mzł 79.92Mzł 45.44Mzł 34.95M
Depreciation and Amortization
zł 4.37Mzł 5.06Mzł 5.44Mzł 7.09Mzł 7.36M
EBITDA
zł -48.84Mzł -32.93Mzł -64.76Mzł -28.22Mzł -24.41M
Operating Income
zł -53.21Mzł -44.76Mzł -73.02Mzł -38.36Mzł -31.71M
Other Income/Expenses
zł 11.21Mzł 541.00Kzł 2.49Mzł 2.47Mzł -863.00K
Pretax Income
zł -42.00Mzł -38.43Mzł -70.53Mzł -35.89Mzł -32.57M
Net Income
zł -42.00Mzł -38.43Mzł -70.58Mzł -35.89Mzł -32.57M
Per Share Metrics
Basic EPS
zł -7.61zł -8.25zł -15.19zł -8.61zł -7.89
Diluted EPS
zł -7.61zł -8.25zł -15.19zł -8.61zł -7.89
Weighted Average Shares Outstanding
 5.52M 4.66M 4.65M 4.17M 4.13M
Weighted Average Shares Outstanding (Diluted)
 5.52M 4.66M 4.65M 4.17M 4.13M
Currency in PLN

Captor Therapeutics SA Earnings and Revenue History